<DOC>
	<DOCNO>NCT01307722</DOCNO>
	<brief_summary>Background Purpose- According prior study , leave atrial ( LA ) distensibility associate significantly leave ventricular filling pressure patient acute myocardial infarction ( AMI ) , chronic stable angina , severe mitral regurgitation . LA distensibility use noninvasive Swan-Ganz catheter . Additionally , could predict in-hospital mortality AMI patient . In current study , leave atrial distensibility guide management advance chronic heart failure perform ass whether management could influence long-term prognosis include mortality rate , rehospitalization rate duration rehospitalization . Materials Methods- Advanced chronic heart failure ( HF ) define left ventricular ejection fraction le 35 % , creatinine le 2 mg/dL , CHF NY functional class III-IV 3 month . Enrolled patient admitted hospital due heart failure require adjustment inotropic agent diuretic within recent 6 month . Three hundred HF case recruit - 100 sinus rhythm , 100 atrial fibrillation serve LA distensibility guide treatment group ( guide group ) another 100 patient , either sinus rhythm atrial fibrillation , serve control group . The management guide group adjust LA distensibility , include dose inotropic agent , diuretic , beta-blocker , ACEI , AIIB . Initially , guide group follow 1 time per 2 week first 3 month , 1 time per month later . The control group treat conventional management traditional echocardiography perform in-charge doctor request . The necessity hospitalization heart failure adjust 2 cardiovascular specialist patient admit heart failure manage one cardiovascular specialist ( Shih-Hung Hsiao ) . The total duration follow-up 2 year . For life-threatening heart failure , intravenous nitroprusside drip continuous A-line monitor , percutaneous coronary intervention , Swan-Ganz catheter insertion , intra-aortic balloon pump , ECMO do accord order in-charge doctor . The primary end-point all-cause mortality . The second end-points heart failure hospitalization duration hospitalization . Additionally , ratio medication change 2-year follow-up , include diuretic , inotropic agent , beta blocker , ACEI , AIIB , assess . Analysis also perform estimate trend heart function ( either systolic diastolic ) renal function 2-year follow-up accord whether guide LA distensibility do .</brief_summary>
	<brief_title>Left Atrial Distensibility Guiding Management Advanced Chronic Heart Failure</brief_title>
	<detailed_description>Background : The use E/Em ( mitral early-diastolic velocity divide mitral early-diastolic annular velocity ) assessing leave ventricular filling pressure innate defect since bear ass regional function myocardium . It rational infer ischemic heart disease regional wall motion defect affect measurement tissue Doppler , thereupon , influence accuracy use regional parameter estimate global function . Conduction disturbance bundle branch block another significant confounder , since truly influence data regional peak Em . Therefore , necessary develop design new global parameter overcome handicap tissue Doppler . In recent study ( 1 , 2 ) , significant logarithmic relationship LV filling pressure LA distensibility patient acute myocardial infarction receive primary percutaneous coronary intervention patient severe mitral regurgitation . In patient receive coronary intervention chronic angina pectoris , relationship also similar ( submit J Am Soc Echocardiogr . major revision ) . In recent ongoing study , LA distensibility apply low-risk general population assess risk stroke , cardiovascular event , mortality presence atrial fibrillation . This time , investigator try use parameter monitor patient advance chronic heart failure ( high-risk group ) adjust patient 's management treatment . Introduction LA volume provide significantly prognostic information general population patient heart disease , include acute myocardial infarction ( 3 ) , leave ventricular dysfunction ( 4 , 5 ) , mitral regurgitation ( 6 ) , cardiomyopathy ( 7 , 8 ) atrial fibrillation ( 9 ) . Large LA volume , represent chronic diastolic dysfunction , associate poor outcome , regardless systolic function ( 10 ) . Thereby , LA volume provide long-term view whether patient disease diastolic dysfunction , regardless whatever load condition present time examination , hemoglobin A1C diabetes mellitus ( 10 ) . Until recently , relation LA volume LV filling pressure confirm directly simultaneous echocardiography-catheterization , study conduce team ( 1 , 2 ) . LA distensibility associate logarithmically leave ventricular filling pressure patient chronic stable angina , acute myocardial infarction , severe mitral regurgitation . It treat non-invasive Swan-Ganz catheter , n't likely affect tissue Doppler confounders regional wall motion defect bundle branch block . Since relationship LA distensibility leave ventricular filling pressure logarithmic , LA distensibility would relatively insensitive low-pressure end . Therefore , investigator conduct investigation ass risk stratification cardiovascular risk LA distensibility low-risk general population ( potential low leave ventricular filling pressure ) 2009 . This time , LA distensibility use guide treatment advance chronic heart failure . Methods Study population : Advanced chronic heart failure ( HF ) define left ventricular ejection fraction le 35 % , creatinine le 2 mg/dL , CHF NY functional class III-IV 3 month . Enrolled patient admitted hospital due heart failure require adjustment inotropic agent diuretic within recent 6 month . Three hundred HF case recruit - 100 sinus rhythm , 100 atrial fibrillation serve LA distensibility guide treatment group ( guide group ) another 100 patient , either sinus rhythm atrial fibrillation , serve control group . The management guide group adjust LA distensibility , include adjustment inotropic agent , diuretic , beta-blocker , ACEI , AIIB . The control group treat conventional management traditional echocardiography perform in-charge doctor request . Renal function check 1 time per 3 month . All patient give write informed consent participate study , study send institutional review board approval . Conventional echocardiographic myocardial tissue Doppler measurement : Echocardiography perform patient initially . LV ejection fraction calculate use Simpson 's method biplane image . Mitral inflow assess pulsed-wave Doppler echocardiography form apical 4-chamber view . From mitral inflow profile , E-wave velocity , A-wave velocity , E-deceleration time measure . Pulsed-wave tissue Doppler imaging ( TDI ) perform use spectral pulse Doppler signal filter , adjust Nyquist limit 15 - 20 cm/s use minimum optimal gain . In apical 4-chamber view , 3-mm , pulsed-wave Doppler sample volume place level mitral annulus septal border . Pulsed-wave TDI result characterize myocardial systolic wave ( Sm ) 2 diastolic wave : early ( Em ) atrial contraction ( Am ) . The pulsed-wave TDI tracing record 5 cardiac cycle sweep speed 100 mm/s use offline calculation . Measurements LA volume : All LA volume measurement calculate apical 4- 2-chamber view use biplane area-length method ( 11 ) . The LA volume measure 3 point : 1 ) immediately mitral valve open ( maximal LA volume Volmax ) ; 2 ) onset P-wave electrocardiography ( pre-atrial contraction volume Volp ) ; 3 ) mitral valve closure ( minimal LA volume Volmin ) . The LA distensibility calculate ( Volmax - Volmin ) / Volmin . The LA ejection fraction calculate ( Volp - Volmin ) / Volp . In patient , LA volumes indexed body surface area ( BSA ) ( 12 ) . For patient atrial fibrillation , average 5 LA distensibilities use clinical assessment . Study Design : This study prospective , observational , open label investigation . The guide group follow 1 time per 2 week first 3 month , 1 time per month later , 1 time per 3 month . Each time , guide group receive echocardiography , include measurement LA distensibility . LA distensibility-guided therapy enable 2 way . Prescriptions adjust accord overall left ventricular fill pressure estimate LA distensibility . The specified treatment adjustment current LA distensibility also allow . Investigators individually adjust medication patient accord range LA distensibility . The specified therapy base 5 LA distensibility range ( low , low , optimal , high , high ) . Each range associate prescription medication dosing , sodium fluid intake , activity level . Although specific prescribe rule ad dynamic prescribing discretion investigator , general aim reduce eliminate diuretic dos high high LA distensibility increase diuretic vasodilator dos low low LA distensibility . The necessity hospitalization heart failure adjust 2 cardiovascular specialist patient admit heart failure manage one cardiovascular specialist . The total duration follow-up 2 year . Patients encourage take additional visit worsening symptom . For life-threatening heart failure , intravenous nitroprusside drip continuous A-line monitor , percutaneous coronary intervention , Swan-Ganz catheter insertion , intra-aortic balloon pump , ECMO do accord order in-charge doctor . The primary end-point all-cause mortality . The second end-points heart failure hospitalization duration hospitalization . Additionally , ratio medication change 2-year follow-up , include diuretic , inotropic agent , beta blocker , ACEI , AIIB , assess . Analysis also perform estimate trend heart function ( either systolic diastolic ) renal function 2-year follow-up accord whether guide LA distensibility do . Interobserver variability : In first 50 enrolled case , Volmax , Volmin , Volp measure 2 independent observer . Interobserver variability calculate difference value obtain 2 observer divide mean . Interobserver difference variability Volmax , Volmin , Volp assess . Statistical analysis : The SPSS software ( version 12 ) use statistical analysis . All continuous variable present mean Â± standard deviation . Analysis variance post hoc test ( Scheffe F-test ) unpaired data use evaluate significance difference group . A p vale &lt; 0.05 consider statistically significant . Comparison clinical characteristic perform chi-square analysis categorical variable . Bivariate analysis , simple correlation linear regression use appropriate . Target ACEI , AIIB , beta blocker dos define &gt; 50 % maximal American Heart Association/American College Cardiology heart failure guideline dos . LA distensibility control empirically define frequency LA distensibility &lt; 90 % ( accord logarithmic regression curve acute myocardial infarction patient , LA distensibility &lt; 90 % indicated leave ventricular filling pressure 15 mmHg prior study ) less 10 % 6 consecutive month . ROC curve analysis perform assess sensitivity specificity cut-off point LA distensibility predict hospitalization heart failure duration hospital stay . Kaplan-Meier curve perform assess cumulative event-free rate accord subgroup analysis ( guide group sinus rhythm , guide group atrial fibrillation control group ) . To evaluate effect covariates mortality heart failure hospitalization , relative risk 95 % confidence interval calculate hazard ratio derive Cox proportional-hazards model . Solutions Anticipated Difficulty The problem unify echocardiographic measurement leave atrial border sonographers participate study . Therefore , investigator perform measurement 50 consecutive patient schedule routine echocardiography discus case reduce technique 's error measurement . Anticipated result : 1 . LA distensibility useful guide management advance chronic heart failure . 2 . The treatment adjust LA distensibility provide advanced information clinical physician . Therefore , potentially influence patient 's outcome . The hypothesis confirm comparison primary second end-points treatment group control group . 3 . Although patient sinus rhythm well ass LA distensibility , average 5 LA distensibilities patient atrial fibrillation possibly useful patient sinus rhythm . Subgroup analysis treatment group accord whether sinus rhythm atrial fibrillation do assess feasibility LA distensibility .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Advanced chronic heart failure ( HF ) define left ventricular ejection fraction le 35 % , creatinine le 2 mg/dL , CHF NY functional class IIIIV 3 month . Enrolled patient admitted hospital due heart failure require adjustment inotropic agent diuretic within recent 6 month . 1. presence mitral stenosis prosthetic mitral valve 2. abnormality atrial septum ( e.g. , atrial septal defect aneurysm ) 3. inadequate image quality 4. lack informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>leave atrial distensibility</keyword>
	<keyword>advanced chronic heart failure</keyword>
	<keyword>decompensation</keyword>
	<keyword>rehospitalization</keyword>
	<keyword>prognosis</keyword>
	<keyword>all-cause mortality</keyword>
	<keyword>heart failure hospitalization</keyword>
	<keyword>duration hospitalization</keyword>
</DOC>